The landscape of dementia analysis has developed dramatically with the advent of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-centered tests that will detect Alzheimer's pathology several years in advance of symptoms emerge. Whilst these technological developments symbolize amazing development in being familiar with neurodege